What Is Insulin and Glucagon? 7 Key Product Attributes Explained
Published: July 19, 2026 16:39
Author: Min-Ah Fernandez
Abstract: Insulin and glucagon are critical peptide hormones regulating blood glucose. This analysis explores their product attributes, comparing brands (e.g., Novo Nordisk vs. Eli Lilly) on purity, stability, and delivery tech. Market trends show a 12.4% CAGR for peptide therapeutics (2024-2030), driven by diabetes/obesity demand. Key differentiators include analog vs. human insulin, half-life, and cold-chain logistics. Factory GMP certifications and USP/EP compliance are vital for quality. Selection tips prioritize bioactivity and impurity profiles (<0.5%). The sector’s future hinges on oral/non-injectable formulations and biosimilar competition.